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Abstract
Purpose To evaluate moderately complex renal cysts of
Bosniak category IIF.
Materials and methods The regional ethics committee ap-
proved the study. In the period 2003–2009, radiological CT
reports of 8,402 CT examinations of the kidneys were
analysed retrospectively by one radiologist. All complex
cystic lesions in the kidney (n=550 in the same number of
patients) were reclassified according to the Bosniak classi-
fication by two radiologists in consensus. If a patient had
more than one lesion, only the highest Bosniak category was
recorded. All Bosniak IIF lesions with ≥2-year follow-up
were included in the study.
Results Thirty-two Bosniak IIF lesions were found. Five
lesions (16 %) were upgraded during follow-up and the pa-
tients were offered surgery. Pathology of three lesions showed
papillary carcinoma, clear cell renal carcinoma and chronic
inflammation, respectively. Due to comorbidity the remaining
two patients were followed with CTwithout intervention. Ten
lesions (31 %) with follow-up periods >5 years had no further
radiological changes and clinical follow-up was stopped.
Conclusion The use of Bosniak category IIF is clinically
applicable, resulting in an overall surgical nephron-sparing
approach to complex renal cysts.
Teaching Points
• The Bosniak classification is used to categorise complex
renal cystic masses
• BIIF cysts behave mostly as benign lesions
• Radiological progression in complexity occurs in only
16 % of cases
• BIIF category seems promising for clinical application,
potentially avoiding unnecessary surgery
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Abbreviations
HU Hounsfield units
PACS Picture-archiving communication system
DLP Dose length product
mSv Millisievert
mA Milliampere
Introduction
Many lesions in the kidney are discovered by coinci-
dence because of increased use of modern imaging
modalities such as ultrasonography (US), computerised
tomography (CT) and magnetic resonance imaging
(MRI) [1–3]. Renal cysts are rare in children (0.1 %–
0.45 %) and common in adults, with approximately
50 % of individuals over 50 years of age having renal
cysts [2, 4]. Renal cysts are most often simple and
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asymptomatic. Distinguishing simple renal cysts from
solid tumours in the kidney does not represent a diag-
nostic challenge. Complex renal cysts, on the other
hand, are still a clinical problem [2, 5, 6]. The most
important element in the diagnostic categorisation of
complex renal cysts is to be able to differentiate be-
tween benign and possibly malignant lesions—in other
words to identify (1) which lesions require surgical
intervention, (2) which can be safely followed by imag-
ing and (3) which are unequivocally benign and need
no surgical intervention or imaging follow-up.
The Bosniak classification is a diagnostic system for
the differentiation of cystic renal lesions in the kidney
using CT. It was introduced in 1986 and has been
updated several times, most recently in 2005 [5]. The
classification system is based on several morphological
changes in renal cysts: septa formation, wall thickening
including nodal components, calcification in the wall
and/or septa, hyperdense cystic content and contrast
enhancement after intravenous contrast injection. The
cystic lesions in the kidney are divided into four cate-
gories using CT. Bosniak category I and II lesions are
predicted to be benign, category III potential malignant
and IV predominantly malignant. Category IIF (BIIF)
has subsequently been introduced for those cysts that
cannot be clearly categorised as category II or III and
therefore need follow-up imaging. Since 1993, when
M.A. Bosniak added the category IIF, few studies have
been published regarding this subject and only three
series with more than ten BIIF lesions [6–13].
The aim of this study was to investigate the usefulness of
Bosniak category IIF and evaluate the clinical outcome of
moderately complex renal cysts compared to published data
in the literature.
Materials and methods
The regional ethics committee approved the study, project
ID: S-20090137. In a 7-year period (January 2003-
December 2009) radiological reports from 8,402 CT exam-
inations of the kidney were analysed retrospectively by one
radiologist with 5 years' experience. All patients with com-
plex renal cysts and normal renal function (estimated creat-
inine clearance >60 ml/min/1.74 m2) diagnosed on
multiphase contrast-enhanced CT and with ≥2-year follow-
up were included in the study (n=550). The lesions on the
CT examinations were reclassified according to the Bosniak
classification by two experienced uroradiologists with
5 years and 20 years of experience, respectively. The image
analysis was performed in consensus. All patients were
recruited from one institution and were examined with the
same follow-up protocol and with the same CT scanner and
CT protocol. The complexity of each lesion was assessed
according to the Bosniak classification on the basis of the
number and appearance of the septa, wall thickness,
hyperdense cystic content, interface with the kidney paren-
chyma, presence and amount of calcification, and contrast
enhancement characteristics. Lesion size was measured in
two dimensions on the axial image. Follow-up examinations
were evaluated for any interval change. Estimated radiation
exposure for each CTscan, represented inmSv, was calculated
with the conversion factor, 0.017 mSv/mGy × cm × the dose
length product (DLP).
In this study only Bosniak category IIF cysts were in-
cluded. From the total number of BIIF lesions we selected
patients with ≥2 years of follow-up. This group was divided
into (1) stable BIIF lesions with follow-up of 2–5 years, (2)
stable BIIF lesions with follow-up of ≥5 years and (3) those
BIIF lesions that progressed in complexity and therefore
Fig. 1 Flowchart
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were upgraded to BIII. None of the patients had more than
one BIIF cyst.
A literature search was performed with Entrez PubMed
for the period 1986–2012 (key words: Bosniak classifica-
tion, renal cysts, renal cell carcinoma, renal cancer, RCC,
computed tomography, CT, magnetic resonance imaging,
MRI, US, contrast-enhanced ultrasonography, CEUS). Only
English-language publications were included.
Imaging
The patient was assessed while supine using a CT scanner
(SOMATOM Sensation 4, Siemens Medical Solutions, Germa-
ny). Patients were orally administrated 500 ml water 30 min
prior to the examination. The scan range field of view (FoV),
including only the kidneys and adrenal glands, was at the skin
level. Before contrast injection an unenhanced CT was
performed. A bolus of 90 ml iodine contrast (Visipaque®
320 mg/ml, Iodixanol, GE Healthcare) was injected intrave-
nously followed by a 20 ml saline solution (0.9 % NaCl) flush
with an injection rate of 4 ml/s. To obtain correct and repro-
ducible contrast phases, the arterial contrast concentration was
monitored with the region of interest (ROI) in the abdominal
aorta at diaphragm level with a trigger level at 100 Hounsfield
units (HU). Corticomedullary and nephrographic phase images
were performed 10 and 65 s after the trigger. Scanning param-
eters were kept the same: 2.5 mm collimation×4; table speed
12.5 mm/s (pitch, 1.25 mm); 165 mAs; 120 kV; 512×512
matrix. All images were reconstructed with a soft algorithm
and WW/WL at 400/40 in transversal, coronal and sagittal
orientation in 3-mm slice thickness with an overlap of 2 mm.
Results
The flowchart (Fig. 1) shows that of 550 complex renal
cysts≥Bosniak category II, 44 patients had moderately
Fig. 2 Transversal baseline a corticomedullary phase CT image of a
61-year-old male with a moderately complex renal cystic lesion show-
ing minimal thickening of the wall and septa without enhancement
(arrow), interpreted as BIIF. Transversal b corticomedullary phase and
c nephrographic phase CT images after 4-year follow-up: The lesion
progressed in complexity with enlargement of the intrarenal compo-
nent leading to up-classification to BIII. Pathological diagnosis was
clear cell renal carcinoma, primarily located focally in the septum
Fig. 3 Transversal baseline a corticomedullary phase CT image of a
61-year-old male with a moderately complex renal cystic lesion show-
ing minimal thickening and calcification of the wall without enhance-
ment (arrow), interpreted as BIIF. After 2-year follow-up the lesion
progressed in complexity with a more irregular wall and was up-
classified to BIII. Transversal b corticomedullary phase and c
nephrographic phase images showing slightly thickened, partially cal-
cified wall without measurable contrast enhancement (arrowhead)
after the lesion had been up-classified. Pathologic diagnosis was pap-
illary renal cell carcinoma
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complex renal cysts categorised as Bosniak IIF. For those
BIIF lesions with a follow-up period ≥2 years (n=32), the
mean follow-up was 1,393 days (735–4,046 days). Sixteen
per cent (5/32) were upgraded to category BIII within a
mean follow-up period of 3 years (735–1,539 days). Six
patients had no follow-up CT and were excluded: two pa-
tients died from other disease, two patients had severe
comorbidity, one patient did not wish to participate in the
follow-up programme, and one patient, 14 years of age, was
lost to follow-up. Mean radiation dose was 12.8 mSv (7–
30 mSv).
In the five patients who were upgraded, three underwent
surgery, and the pathology of these three lesions showed
papillary carcinoma, clear cell renal carcinoma (Figs. 2 and
3) and chronic inflammation with no malignancy, respec-
tively. Due to comorbidity, the other two patients were not
treated surgically; however at CT follow-up they did not
show any further progression. Thirty-one per cent (10/32) of
the lesions with mean follow-up periods >5 years (mean
1923 days, range 1229–4046 days) were stable during
follow-up, suggesting benignity (Fig. 4). Table 1 presents
a detailed summery of the cohort. Figures 5, 6, 7, 8, 9 and 10
show four different BIIF lesions from the cohort and exam-
ples of BII and BIII cysts.
Discussion
Classification and treatment of complex renal cysts repre-
sent a clinical challenge, demanding close cooperation be-
tween urologists and uroradiologists. Bosniak revised the
original classification system of renal cysts in 1993 to in-
clude a subset of category II lesions, category IIF cysts [5, 6,
14]. This category represents more complex cystic lesions,
which cannot unequivocally be classified as category II or III.
According to Bosniak, these cysts are potentially malignant
Table 1 Summary of the cohort
Total BIIF BIIF BIIF BIII
Follow-up
≥2 years
Follow-up 2–
5 years
Follow-up
>5 years
BIIF upgraded during
follow-up
Number of lesions with follow-up ≥2 years 44 32 17 10 5
Sex (male/female) 26/18 17/15 8/9 5/5 4/1
Mean age in years 66.64 65.31 64.59 66.10 66.20
(Range) (14–87) (40–87) (40–87) (46–83) (61–80)
Mean follow-up time in days 962 1,393 1,164 1,923 1,113
(Range) (0–4,046) (735–4,046) (760–1,956) (1,229–4,046) (735–1,539)
Mean lesion size in mm A × B* 37 × 30 37 × 30 39 × 33 34 × 27 36 × 28
(Range) (6–98) ×
(6–81)
(13–77) ×
(8–73)
(13–77) ×
(10–73)
(13–77) ×
(8–63)
(17–75) × (11–60)
Lesion changes in size 36/8/0 24/8/0 12/5/0 9/1/0 3/2/0
Stable/increase/decrease
Number of septa (0/<5/5-9/>9) 30/9/2/3 19/8/2/3 10/5/0/2 7/1//2/0 2/2/0/1
Septal appearance (none/thin/thickened) 30/5/9 19/5/8 10/2/5 7/2/1 2/1/2
Calcification (None/minimal/mild/moderate/
massive)
21/4/10/9/0 12/4/8/8/0 6/1/6/4/0 3/3/1/3/0 3/0/1/1/0
Lesion interface with kidney parenchyma
(sharp/indistinct)
42/2 30/2 17/0 10/0 3/2
Contrast enhancement (none/enhancement/
maybe)
36/0/8 24/0/8 15/0/2 8/0/2 1/0/4
*Lesion size was measured in two dimensions on the axial image
Fig. 4 Corticomedullary phase CT images in a transversal plane and b
coronal plane of a 68-year-old male with a moderately complex renal
cystic lesion (arrow) showing hairline-thin smooth septa and wall with
minimal thickening and calcification of septa without measurable
contrast enhancement (arrowhead). There was no progression of the
lesion after 5-year follow-up
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and should be followed with CT examinations, performed to
determine whether the cystic lesions change over time with
regard to morphology and contrast enhancement pattern, sub-
sequently resulting in an up- or downgrading [6, 9, 15, 16].
Category IIF moderately complex renal cysts may contain
increased numbers of thin septa or a slightly thickened but
smooth septum/septa or wall. They may also contain calcifi-
cations that may be thick and nodular, but without contrast-
enhancing elements. Completely intrarenal high-attenuation
cysts ≥3 cm also belong to this group.
Cystic lesions in the kidney may have a variety of differ-
ent aetiologies [2]. Most malignant complex renal cysts are
cystic renal cell carcinomas (CRCC). Like the multilocular
cystic renal cell carcinoma (MCRCC), CRCC has a very
good prognosis. They are slow growing and have a low
metastatic potential [7, 17–20]. Due to benign changes with
solid components like in mixed epithelial and stromal tu-
mours (MEST), there will always be some benign lesions
among the categories BIIF and above. These lesions are
very rare, however [21]. Therefore, nephron-sparing surgery
is proposed when MCRCC is suspected by preoperative
radiologic criteria.
The Bosniak classification consists of a number of differ-
ent entities including septa characteristics and enhancement,
potentially resulting in differences of interpretation among
readers [1–3]. In order to validate the classification system
further, studies regarding intra- and interobserver variation after
the introduction of the updated version of the Bosniak classifi-
cation are warranted. The best results are probably seen when
radiologists are categorising complex renal cysts in plenum, as
in our study [1, 2, 4, 12, 22].
Bosniak classification and clinical outcome
Moderately and more complex renal cysts of category BIIF
and above are quite rare, and consequently data with corre-
sponding pathological findings are sparse. When BIIF le-
sions progress in terms of enhancement, changes in internal
architecture by developing irregular, thick enhancing septa,
Fig. 5 Transversal a non-contrast, b corticomedullary phase and c
nephrographic phase CT image of a 66-year-old female with a moder-
ately complex renal cystic lesion (arrow) showing few septa without
measurable contrast enhancement (arrowhead), interpreted as BIIF.
During the last 3-year follow-up, the lesion progressed in size but not
in complexity. Note the small hemangioma in the liver
Fig 6 Transversal a non-contrast, b corticomedullary phase and c
nephrographic phase CT image of a 70-year-old female with an inde-
terminate complex renal cystic mass (arrow) showing multiple septa
with calcification and a suspicious nodular area without measurable
contrast enhancement. The arrowheads show one example of such a
suspicious area. The lesion was interpreted as BIIF but very close to a
BIII and has been stable for the first 2 years of follow-up
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solid components or multilocular characteristics, they are
upgraded, and interventions are recommended. Published
series with more than 20 complex renal cysts with patholog-
ical findings are presented in Table 2. In the BIIF group, the
12 % malignancy rate represents BIIF lesions with radiolog-
ical progression in complexity over time and subsequent
upgrading. Compared to the distribution of malignancy in
each Bosniak category in publications before the introduction
of BIIF, the accuracy of predicting malignancy in BIII lesions
has improved from 51 % to 61 % after the introduction of
BIIF, which means that by introducing this category approx-
imately 10 % could be spared surgical intervention. Surpris-
ingly, the malignancy rate in the BII category is still
unacceptably high (12 %), even in the series published after
the introduction of BIIF.
We found 44 BIIF moderately complex renal cysts
among 8,402 CT examinations of the kidneys in a 7-year
period. During the follow-up 16 % (5/32) of the lesions
progressed radiologically, which corresponds well with the
literature (Table 2). Unfortunately, we do not have histolog-
ical specimens of all five BIIF lesions that progressed
radiologically because of co-morbidity of the patients. Two
of three BIIF lesions with proven histology were malignant,
indicating that radiological progression is indicative of ma-
lignancy. On the other hand, the two patients for whom
histology was not available did not progress further radio-
logically during a mean follow-up of more than 3 years,
suggesting that these lesions are either benign or low-grade
aggressive.
Imaging
Several studies report that the chance of malignancy in-
creases to 40–80 % when enhancement is observed within
a renal cystic lesion [5, 10, 12, 17, 23]. It is therefore of
upmost importance that categorisation of complex cystic
changes in the kidney is performed with high-quality CT
in several phases. To detect enhancement in small areas such
as a septum or the wall of a cyst, one cannot rely on split
bolus CT examinations that present both corticomedullary
and excretory phases in one examination. RCCs are often
Fig 7 Transversal a non-contrast, b corticomedullary phase and c
coronal nephrographic phase CT image of a 69-year-old female with
a moderately complex renal cystic mass (arrow) showing the wall and
some septa containing thick and nodular calcification (arrowhead).
The lesion was interpreted as BIIF; no progression was seen after
4 years of follow-up
Fig. 8 Baseline transversal a non-contrast, b corticomedullary phase
and c nephrographic phase CT image of a 64-year-old female with an
indeterminate complex renal cystic mass (arrow) showing multiple
septa with calcification and some slightly thickened septa with
perceived enhancement (arrowhead). The lesion was interpreted as
BIIF and has been stable for the first 3 years with MRI follow-up
(not shown)
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hypervascular and therefore have a characteristic contrast
enhancement pattern characterised by washout in the venous
phase [33]. Usually protocols for characterising complex
renal cysts consist of a CT without contrast (non-contrast
CT, NCCT) and a minimum of two CT single-bolus phases
with contrast-enhanced CT and CCT in an arterial and
venous phase, respectively [2, 5]. Most radiologists would
agree that pre- and post-contrast CT examinations are man-
datory, but the number of post-contrast phases is debatable.
In most centres a multidetector CT (MDCT) is available
with the possibility of performing isotropic multiplanar re-
construction in high quality. Technically, there are different
software opportunities for CT—including software
algorithms—to help assess iodine content in a lesion or
dual-energy modes to gain additional/alternative informa-
tion regarding complex renal cystic masses. Preliminary
data are available in the literature regarding these issues
[34, 35] but further studies are needed.
It is estimated that the risk of getting a fatal cancer from the
ionised radiation of CT scans is approximately 1/1,000 for
every 10 mSv received, assuming an effective dose of 10 mSv
per scan and a risk of 5 % per Sievert [36]. One study suggests
that 2 % of all future cancers may be due to radiation exposure
from CT examinations [37]. This statement has been widely
criticised and the numbers are probably lower [38, 39].
Depending on patient size and body habitus, radiation doses
from CTare often quite high—in the range of and even above
20–30 mSv in case of 64-channel CT scanners. In our study
the mean radiation dose was 12.8 mSv (7–30 mSv) on our
four-channel CT. It is very important to perform radiological
imaging according to the ALARA principle. This means that
patients, regardless of age and disease, should be examined
selectively with radiation doses “as low as reasonably
achievably” according to the clinical problem in question.
The Bosniak classification was initially developed solely on
the basis of CT findings [1, 2]. Subsequently, a few studies
have suggested that MR [31, 40] and CEUS [4, 8, 41–46] may
be equally useful for characterisation of complex renal cystic
masses. Results from these studies are promising. However,
both MR [31] and CEUS [8, 45, 46] have a tendency to
Fig 9 Transversal a non-contrast, b corticomedullary phase and c nephrographic phase CT image of a 85-year-old male with a typical benign BII
exofytic hyperdense cyst (arrow) measuring 35 HU in all phases
Fig 10 CT images of an 85-year-old male with a large renal cell
tumour on the right side (not shown) and a left-sided indeterminate
complex renal cyst with thickened enhancing wall, categorised as BIII.
The patient underwent right-sided nephrectomy and percutaneous
cryoablation on the left side. Transversal corticomedullary phase CT
images of (a) baseline and (b) 3 month after right-sided nephrectomy.
The BIII lesion (arrow) is almost solid after 3 months, indicating
aggressive behaviour. No progression was seen at 6-month follow-up
imaging after percutaneous cryoablation (c)
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upgrade lesions, probably because of the superior contrast
resolution compared to CT. The literature is still unequivocal
on whether the higher contrast resolution of MR and CEUS
will result in earlier detection of potential malignant lesions or
inappropriate higher false-positive rates. Further research re-
garding the role of MR and CEUS are needed and
forthcoming.
Follow-up imaging for BIIF lesions
Recommended follow-up protocols for BIIF cystic lesions
vary in the literature. To detect potential progression, a
multiphase contrast CT is needed. M.A. Bosniak proposed
the first control CT to be done after half a year, and if the
lesion was unchanged, a control CT should be repeated annu-
ally for a minimum of 5 years [6]. Other authors recommend
close monitoring in the first year with CT scans after 3, 6 and
12 months. At our institution patients with complex Bosniak
IIF cysts used to be followed according to the latter protocol
and in cases without progression annually for 5 years. It
should, however, be noted that very narrow follow-up periods
may reduce detection rates if the changes in the cysts from
examination to examination are very small. As a consequence
of these considerations and the results of this study, we have
dropped the early 3-month follow-up. However, due to the
lack of prospective series, the most appropriate follow-up
regimen in these patients is still debatable [9].
Table 2 Published series with more than 20 complex renal cysts with pathological findings
References Modality BI BII BIIF BIII BIV Total
Before introduction of BIIF
Brown et al. (1989) [23] CT 0/2 0/4 – 3/12 4/6 24
Aronson et al. (1991) [24] CT – 0/4 – 5/9 7/7 20
Wilson et al. (1996) [25] CT 0/7 4/5 – 4/4 6/6 22
Cloix et al. (1996) [17] CT 1/2 1/7 – 4/13 7/10 32
Siegel et al. (1997) [3] CT 0/22 1/8 – 5/11 26/29 70
Bielsa et al. (1999) [26] CT – 1/8 – 7/9 3/3 20
Koga et al. (2000) [19] CT 0/11 1/2 – 10/10 12/12 35
Curry et al. (2000) [27] CT 0/4 0/11 – 29/49 18/18 82
Limb et al. (2002) [28] CT – 3/28 – 8/29 – 57
Overall number 1/48 11/77 – 75/146 83/91 362
Malignant vs. benign
Incidence of malignancy (%) 2 % 14 % – 51 % 91 %
References Modality BI BII BIIF# BIII BIV Total
After introduction of BIIF
Isreal et al. (2003) [29] CT – – – 9/21 16/16 37
Isreal et al. (2003) [6] CT – – 7/42 – – 42
Harisinghani et al. (2003) [30] CT – – – 17/28 – 28
Isreal et al. (2004) [31] CT and MRI – – – 14/14 6/6 20
Spaliviero et al. (2005) [7] CT 2/9 1/4 6/12 19/21 46
Quaia et al. (2008) [8] CT and CEUS – 0/3 0/6 5/13 18/18 40
O’Malley (2009) [9] CT – – 5/74 27/33 107
Gahr et al. (2009)* [10] CT – – 7/50 – – 50
Song et al. (2009) [11] CT – 3/26 0/3 21/38 32/37 104
Peng et al. (2010) [4] CT and CEUS 0/2 0/3 – 5/6 12/13 24
Kim et al. (2010) [12] CT 0/34 3/22 3/10 19/26 28/33 125
Weibl et al. (2011) [22] CT and MRI – 0/2 2/3 15/27 30/39 71
Pinheiro et al. (2011) [20] CT 5/15 19/22 37
You et al. (2011) [32] CT – – – 22/39 31/36 75
Our study CT – – 2/38 – – 38
Overall number 0/36 8/65 27/230 165/272 211/241 844
Malignant vs. benign
Incidence of malignancy (%) 0 % 12 % 12 % 61 % 88 %
*BII and BIIF lesions were pooled
# BIIF cysts that progressed and histologically were verified as malignant
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Bosniak IIF lesions vary in appearance: (1) BIIF lesions
with minimal findings close to category II in complexity and
(2) BIIF lesions that are closer to category III in complexity.
M.A. Bosniak has recently suggested that BIIF cysts with
minimal findings only need follow-up for 1–2-years, whereas
more complex BIIF cysts should be followed for a longer
period (e.g., 3–4 years or longer) [1]. This seems to be a
reasonable compromise taking into consideration the high,
cumulated radiation dose of repeated examinations. CT is still
considered the gold standard when categorising complex renal
cystic masses. For BIIF lesions an early switch to MRI/CEUS
with a baseline examination immediately following the CT
examination is now used at many institutions. Long-term data
on such a regime may change clinical management in the
future. Caution must be made for lesions ≤2 cm [1]. We have
chosen to stop follow-up if no progression is seen after 5 years,
suggesting that the BIIF lesion was benign. To our knowledge
this has only been debated very sparsely in the literature, and
studies on the most appropriate follow-up regimen in these
patients are, as mentioned, warranted [1, 2, 5, 47].
Biopsy and minimally invasive intervention
Biopsy of moderate complex cystic masses in the kidney has
recently come into focus and the trend seems to be a more
aggressive approach [2, 9, 15, 30, 48, 49]. This is presumably
to avoid follow-up imaging of those BIIF lesions that are close
to BIII and undoubtedly due to the possibility of using local
nephron-sparing treatment (ablation with cryo/radiofrequency
therapy and/or laparoscopic resection). Whether biopsy and
aspiration of the cyst fluid should be used routinely is contro-
versial. It may be problematic to accept a negative biopsy
result since the renal cysts usually are very inhomogeneous. In
general, it is recommended that Bosniak category III and IV
lesions be treated surgically or with minimally invasive abla-
tion measures. The treatment strategy depends on the size and
localisation of the lesion and the patient’s general condition. It
should be noted, however, that the indication for minimally
invasive treatment in cases with suspected malignancy is still
regarded as being in the exploratory phase. Routine use of
these minimally invasive methods should therefore be
protocolised and results published.
Although our numbers are small, the data seem to be
consistent in the regard that if progression occurs radiologi-
cally, it corresponds to pathological results. The correspond-
ing aggressiveness of the lesions needs further evaluation in
prospective studies, however. Our cases were analysed in
consensus, so interobserver variability could not be evaluated.
Like M.A. Bosniak, we believe that, if the complexity of a
category II lesion is in question, the lesion should be placed in
category IIF. In cases of disagreement among the radiologists,
the lesion should always be placed in the highest category [5,
13, 47, 50]. Furthermore, decisions on the interventionmay be
easily influenced by clinical parameters, as in our series, in
which surgical resection was omitted because of co-morbidity.
Other comparable studies have the same limitationwith regard
to accordance between radiological and pathological progres-
sion, since not all category IIF lesions that progressed were
resected [6, 9, 10].
Conclusion
By critically evaluating the outcome of complex renal cysts
using the Bosniak classification, we found that out of 32
Bosniak category IIF lesions only 5 (16 %) were upgraded
during follow-up. Malignant progression did occur in two of
these lesions, and follow-up examinations are considered
necessary. The introduction of Bosniak category IIF seems
promising, potentially resulting in a rational and an overall
nephron-sparing approach to complex renal cysts.
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